Cytyc's offer for Digene extended:
This article was originally published in Clinica
Cytyc has extended the expiration date of its offer to buy Digene until April 11 after receiving a request for additional information from the US Federal Trade Commission. The two companies plan to respond promptly to the request. Cytyc announced its $554 million offer in February (see Clinica No 997, p 17).